To determine if the mutations introduced in tRNASec affected tRNA structure and fold, a melt curve analysis was performed. For the melt curve analysis, purified tRNASec samples were first treated with DNase to ensure there was no residual DNA carried over from the transcription reaction. All buffers were prepared with DEPC-treated water to ensure inhibition of RNase activity. For DNase treatment, 10 µg of each purified tRNA was resuspended in 100 µL of 1× DNase I reaction buffer (10 mM Tris–HCl, pH 7.5, 2.5 mM MgCl2, and 0.1 mM CaCl2) with a final DNase I (Thermo Fisher) concentration of 1 U/µL. The reaction was incubated at +37°C for 10 min. Subsequently, the RNA was purified using a RNA Clean & Concentrator kit (Zymo Research) and eluted in a buffer containing 20 mM Tris–HCl, pH 7.5, and 50 mM NaCl. For RNase A treatment of WT tRNASec, a 50 µL reaction containing 500 ng/µL of WT tRNASec was incubated with RNase A (100 µg/mL) in 20 mM Tris–HCl, pH 7.5, and 50 mM NaCl, at +37°C for 10 min. For tracking RNA denaturation, a 1:20,000 SYBR Green I Nucleic Acid Gel Stain (Thermo Fisher) dilution gave a superior signal-to-noise level. Practically, a 10× SYBR Green I Buffer was prepared in 100 mM Tris–HCl, pH 7.5, 20 mM MgCl2, 1.5% (v/v) Triton X-100, and 1.5 M NaCl by diluting the original dye 2000-fold. This solution could be stored at +4°C for up to a week. To prepare samples for the melt curve analysis, each tRNA sample (no RNA, WT tRNASec, mutants 1-10, and RNase A-treated WT tRNASec) was diluted in the 1× SYBR Green I Buffer to a concentration of 60 ng/µL. The melt curve analysis was performed in triplicate using a 20 µL sample volume on a Bio-Rad CFX Connect instrument with a temperature gradient of 0.5°C/s from +50 to +95°C. The Tm was best visualized as a clear peak in the negative first derivative of the melting curve (−dRFU/dT).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.